Chemical Structure (Emend 01)
Emend Injection, Powder, Lyophilized, For Solution
Product Images NDC 0006-3061
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Emend (NDC 0006-3061). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Merck Sharp & Dohme Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Principal Display Panel (150 mg Vial Carton)
Emend® is a sterile lyophilized powder for intravenous use only after reconstitution and dilution. Each vial contains 150 mg of fosaprepitant as an active ingredient. The powder should be reconstituted with 5 mL of 0.9% Sodium Chloride for Injection. The drug should not be used with solutions containing divalent cations, including lactated Ringer's solution and Hartmann's solution. Once prepared, the drug is stable for 24 hours at ambient temperature or below 25°C. The medication comes in single-dose vials, and any unused portion should be discarded. The usual dosage should be followed as per the prescribing information. Emend® is manufactured by Merck, and the active ingredient is formulated in the USA.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
